Wellcome Trust launches investment wing


The Wellcome Trust has provided £200 million to launch an investment company that aims to support innovative healthcare businesses with the potential to transform the markets in which they operate.

The investment company, plans for which were revealed in March 2012, will operate as ‘Syncona’ and look to make investments in the £1–20 million range as a majority investor or as part of a syndicate.

Syncona chief executive Martin Murphy said: ‘We expect to play our part in building successful businesses based upon innovation within the life science and healthcare industry. We very much look forward to working with entrepreneurs, leading academics and inventors to build success stories in the UK, Europe and beyond.’

The Wellcome Trust is one of the largest charitable foundations in the world, spending £600 million per year to support biomedical research and the medical humanities.


Related Content

Wellcome Trust to enforce open access rules

28 June 2012 News and Analysis

news image

UK charitable foundation will cut the grants of scientists who do not make their research freely available

Wellcome Trust announces new head

1 May 2013 News and Analysis

news image

Jeremy Farrar to join the organisation on 1 October

Most Read

Infrared camouflage that sticks

19 February 2015 Research

news image

Nature’s masters of disguise, the cephalopods, inspire inexpensive and disposable stealth coating that could easily be adde...

Nanoporous methane storage – an impossible target?

18 February 2015 Research

news image

Identifying performance limits for nanoporous materials highlights that current methane storage goals might be unrealistic

Most Commented

Nanoporous methane storage – an impossible target?

18 February 2015 Research

news image

Identifying performance limits for nanoporous materials highlights that current methane storage goals might be unrealistic

Enthralled by evaporation

20 February 2015 Organic Matter

news image

A giant rotary evaporator is a mesmerising thing, says Chemjobber, but the plant requires a different approach